Teva Pharmaceutical Industries Ltd. - At the opening of a new scientific research center in the Galilee region of Israel (pictured, left to right): Erez Vigodman, Teva President and CEO; Prof. Ran
Michael Hayden Net Worth (2022) | wallmine
Michael Hayden, MD PhD | CMHF
Sitting down with… Dr Michael Hayden, Prilenia Therapeutics – Drug Discovery World (DDW)
How One of the World's Leading Geneticists Recovered His Family's Stolen Legacy - Tablet Magazine
Former Teva Executives Raise $60 Million for Metabolic Disorders Venture | Ctech
Press release - Sosei Heptares
Teva scraps Heptares migraine pact as lead drug nears clinic | Fierce Biotech
New Teva CEO shakes up structure and leadership at troubled drugmaker | The Times of Israel
Michael Hayden, MD, PhD - World Neuroscience Innovation Forum
Celebrating Biopharma Innovation: The Top 10 | Reuters Events | Pharma
Teva appoints genetics specialist as its first president of global R&D - PMLiVE
Winning the War on Huntington's Disease - WuXi XPress: for WuXi news and R&D insights
Pridopidine and Michael Hayden makes comeback! – European Huntington Association
New Teva CEO shakes up structure and executive ranks as major layoffs loom | Fierce Pharma
Teva and Microchips : Partnership through Digital Drug Delivery Technology. Opening of Teva R&D Center in Croatia - Israël Science Info
Prilenia Therapeutics raises $62.5m, names Michael Hayden CEO - Globes
New Teva CEO axes R&D chief Hayden in boardroom shakeup -
Michael HAYDEN | MBCHb PhD | University of British Columbia - Vancouver, Vancouver | UBC | Department of Medical Genetics
Axovant poaches Allergan's and Teva's chief medical and science officers - PMLiVE
How One of the World's Leading Geneticists Recovered His Family's Stolen Legacy - Tablet Magazine
Michael Hayden - Director at n-Lorem Foundation | The Org
Podcast Transcript Michael Hayden and PROOF-HD v.1 08Jan2021
Teva R&D Strategy
Incisive Genetics
Dr. Michael Hayden MBChB , PhD - Chief Executive Officer - Prilenia | LinkedIn
Meet the Investigator – HD Insights
Senior Advisors copy — Biolojic
Oxford Biomedica Appoints Dr. Michael Hayden as
